Literature DB >> 8739430

Quality of life as a measure of rehabilitation outcome in patients with multiple sclerosis.

A Jønsson1, J Dock, M H Ravnborg.   

Abstract

A total of 43 patients with multiple sclerosis (MS) consecutively admitted to the Multiple Sclerosis Rehabilitation Hospital in Haslev completed a Danish version of the Laman & Lankhorst Questionnaire (LLQ) on quality of life (qol), and the Beck Depression Inventory (BDI). Twenty-one of the 43 pts completed the questionnaires at discharge as well. All patients received the standard multidisciplinary rehabilitative treatment. The purpose was to evaluate the LLQ as a measure of qol and as an outcome measure. The 43 MS-patients had low weighted qol scores on the following items: readily tired, fatigue, dependence on other people, worry about deterioration and walk. Correspondingly, the BDI showed high scores on fatigability, work difficulty and somatic preoccupation. The correlation between LLQ and BDI was statistically significant (0.54, p < 0002), but weak. ANOVA with repeated measures (LLQ and BDI at admission and discharge) was applied to evaluate rehabilitation outcome in 21 patients. LLQ: The patients experienced a significant reduction in disability on fatigue and mood; and in the importance of being able to climb stairs and to work. The weighted qol-scores increased significantly on physical endurance, work and mood. BDI scores showed a significant decrease on pessimism, irritability, loss of libido and total BDI-score. The changes measured by the LLQ were mainly on behavioral aspects. As the correlation coefficient was only 0.54, the LLQ and the BDI seem to address different aspects of quality of life.

Entities:  

Mesh:

Year:  1996        PMID: 8739430     DOI: 10.1111/j.1600-0404.1996.tb00512.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

Review 1.  Quality of life and neurological illness: a review of the literature.

Authors:  R Murrell
Journal:  Neuropsychol Rev       Date:  1999-12       Impact factor: 7.444

2.  Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Authors:  Stefan M Gold; Kyle C Kern; Mary-Frances O'Connor; Michael J Montag; Aileen Kim; Ye S Yoo; Barbara S Giesser; Nancy L Sicotte
Journal:  Biol Psychiatry       Date:  2010-06-19       Impact factor: 13.382

3.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

4.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

5.  Factor structure of the Disability and Impact Profile in patients with multiple sclerosis.

Authors:  L Cohen; F Pouwer; L E Pfennings; G J Lankhorst; H M van der Ploeg; C H Polman; H J Adèr; A Jønnson; L Vleugels
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

6.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 7.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

8.  Biological outcome measurements for behavioral interventions in multiple sclerosis.

Authors:  Anja Fischer; Christoph Heesen; Stefan M Gold
Journal:  Ther Adv Neurol Disord       Date:  2011-07       Impact factor: 6.570

Review 9.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

10.  The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis.

Authors:  Haleh Ghaem; Afshin Borhani Haghighi
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.